benzoxazoles has been researched along with Black Fever in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bello, D; Braillard, S; Caljon, G; Carvalho, S; Corpas-Lopez, V; Freund, Y; Gilbert, IH; Glossop, PA; Jacobs, RT; Lukac, I; Maes, L; Mowbray, CE; Nare, B; Pandi, B; Patterson, S; Speake, J; Van den Kerkhof, M; Wall, RJ; Whitlock, GA; Wyllie, S; Yardley, V; Zuccotto, F | 1 |
| de Almeida, L; de Andrade, CR; Dos Santos, JL; Dutra, LA; Fonseca, JNVD; Graminha, MAS; Imamura, KB; Nascimento, RFQ; Passalacqua, TG | 1 |
2 other study(ies) available for benzoxazoles and Black Fever
| Article | Year |
|---|---|
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Benzoxazoles; Boron Compounds; Cricetinae; Disease Models, Animal; Dogs; Humans; Leishmaniasis, Visceral; Mice; Pyridines; Structure-Activity Relationship | 2021 |
In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Benzoxazoles; Biomarkers; Cricetinae; Kidney; Leishmania infantum; Leishmaniasis, Visceral; Liver; Macrophages; Male; Mice; Nitric Oxide; Spleen; Treatment Outcome | 2017 |